|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Assets, Current | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable | ||||||||||||||||||||
| Inventories, net | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Income taxes receivable | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Right-of-use asset - operating leases | ||||||||||||||||||||
| Deferred income tax assets | ||||||||||||||||||||
| Derivative asset- interest rate swap | ||||||||||||||||||||
| Equity method investment | ||||||||||||||||||||
| Deposits and other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| Liabilities, Current | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Commission payable | ||||||||||||||||||||
| Bonus payable | ||||||||||||||||||||
| Current portion of long-term debt | ||||||||||||||||||||
| Current portion of lease liabilities - operating leases | ||||||||||||||||||||
| Current portion of earnout consideration liability | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Current portion of tax receivable agreement liability | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt, net of deferred finance costs | ||||||||||||||||||||
| Convertible notes | ||||||||||||||||||||
| Derivative liability - convertible notes redemption make-whole provision | ||||||||||||||||||||
| Warrant liability | ||||||||||||||||||||
| Lease liabilities - operating leases | ||||||||||||||||||||
| Earnout consideration liability | ||||||||||||||||||||
| Tax receivable agreement liability | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Redeemable non-controlling interest | ||||||||||||||||||||
| Stockholders’ Equity: | ||||||||||||||||||||
| Preferred stock, $0.0001 par value; 10.0 shares authorized; no shares issued and outstanding | ||||||||||||||||||||
| Class A common stock, $0.0001 par value; 1,000.0 shares were authorized as of September 30, 2026 and December 31, 2025, and 289.9 and 127.0 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Class A Common Stock | ||||||||||||||||||||
| Class B Common Stock | ||||||||||||||||||||
| Treasury shares | ||||||||||||||||||||
| Treasury stock | ||||||||||||||||||||
| Additional paid-in-capital | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders' equity (deficit) | ||||||||||||||||||||
| Total liabilities and stockholders' equity (deficit) | ||||||||||||||||||||
Loading...